JBiSE  Vol.6 No.5 A , May 2013
Evaluation of hearing in middle-aged patients with diabetes mellitus type 2
ABSTRACT
Introduction: Involvement of auditory pathway is one of the examples of central neuropathy in diabetics. The purpose of this study is to compare the auditory function of patients with type 2 diabetes mellitus with healthy subjects. Methodology: 30 diabetic and 30 healthy subjects participated in this study. For all participants conventional pure-tone audiometry (PTA) and Auditory Brainstem Evoked Responses (ABER) study were performed. Results: In PTA Hearing threshold only at 2, 4, 8 KHz frequencies were significantly higher than healthy subjects but were in normal range in patients with diabetes. ABER revealed that absolute latencies of waves I, III, V and inter wave latencies of III-V, I-V, I-III were significantly prolonged in diabetics. Conclusion: In this study, 50% of diabetic patients had hearing defects in ABER test despite normal hearing threshold and good meta-bolic control. Prolonged inter wave latencies of I-III, III-V, I-V explains retrocochlear and brain stem involvement.

Cite this paper
Forogh, B. , Zeinolabedini, R. , Akbari, M. and Mianehsaz, E. (2013) Evaluation of hearing in middle-aged patients with diabetes mellitus type 2. Journal of Biomedical Science and Engineering, 6, 16-19. doi: 10.4236/jbise.2013.65A004.
References
[1]   Sharma, R., Gupta, S.C., Tyagi, I., Kumar, S. and Mukherjee, K. (2000) Brain stem evoked responses in patients with diabetes mellitus. Indian Journal of Otolaryngology and Head & Neck Surgery, 52, 223-229.

[2]   Ferrer, J.P., Biurrun, O., Lorente, J., Conget, J.I., de España, R., Esmatjes, E. and Gomis, R. (1991) Auditory function in young patients with type 1 diabetes mellitus. Diabetes Research and Clinical Practice, 11, 17-22. doi:10.1016/0168-8227(91)90136-2

[3]   Dalton, D.S., Cruickshanks, K.J., Klein, R., Klein, B.E. and Wiley, T.L. (1998) Association of NIDDM and hearing loss. Diabetes Care, 21, 1540-1544. doi:10.2337/diacare.21.9.1540

[4]   Sieger, A., White, N.H., Skinner, M.W. and Spector, G.J. (1983) Auditory function in children with diabetes mellitus. Annals of Otology, Rhinology & Laryngology, 92, 237-241.

[5]   Chiappa, K.H. (1997) Evoked potentials in clinical medicine. Raven Press, New York, 145-147.

[6]   Donald, M.W., Bird, C.E., Lawson, J.S., Letemendia, F.J., Monga, T.N., Surridge, D.H., et al. (1981) Delayed auditory brainstem responses in diabetes mellitus. Journal of Neurology, Neurosurgery & Psychiatry, 44, 641-644. doi:10.1136/jnnp.44.7.641

[7]   Díaz de León-Morales, L.V., Jáuregui-Renaud, K., Garay-Sevilla, M.E., Hernández-Prado, J. and MalacaraHernández, J.M. (2005) Auditory impairment in patients with type 2 diabetes mellitus. Archives of Medical Research, 36, 507-510. doi:10.1016/j.arcmed.2005.02.002

[8]   Akinci, A., Deda, G., Karagöl, U. and Teziç, T. (1994) Brainstem auditory evoked potential, visual evoked potential and nerve conduction velocity and their relation with HbA1c and beta 2 microglobulin in children with insulin dependent diabetes mellitus. The Turkish Journal of Pediatrics, 36, 279-287.

[9]   Bayazit, Y., Yilmaz, M., Kepekçi, Y., Mumbuç, S. and Kanlikama, M. (2000) Use of the auditory brainstem response testing in the clinical evaluation of the patients with diabetes mellitus. Journal of the Neurological Sciences, 181, 29-32.

[10]   Hall, J.W. (2007) New handbook of auditory evoked responses. Pearson Education, Boston, 171-211.

[11]   Durmus, C., Yetiser, S. and Durmus, O. (2004) Auditory brainstem evoked responses in insulin-dependent (ID) and non-insulin-dependent (NID) diabetic subjects with normal hearing. International Journal of Audiology, 43, 29-33. doi:10.1080/14992020400050005

[12]   Konrad-Martin, D., Austin, D.F., Griest, S., McMillan, G.P., McDermott, D. and Fausti, S. (2010) Diabetes-related changes in auditory brainstem responses. Laryngoscope, 120, 150-158. doi:10.1002/lary.20636

[13]   Virtaniemi, J., Laakso, M., Kärjä, J., Nuutinen, J. and Karjalainen, S. (1993) Auditory brainstem latencies in type I (insulindependent) diabetic patients. American Journal of Otolaryngology, 14, 413-418. doi:10.1016/0196-0709(93)90116-O

 
 
Top